-
2024-517529-26-00
5
2025-08-04
Chronic Inflammatory Demyelinating Polyneuropathy
-
2024-512696-12-00
4
2025-06-24
BCR-ABL1+ Chronic Myeloid Leukemia
-
2024-515411-21-00
4
2025-06-18
Rett Syndrome (RTT)
-
2023-507030-24-00
4
2025-04-30
Persistent Corneal Epithelial Defects
-
2024-511495-32-00
5
2025-04-16
Chronic Phase Chronic Myeloid Leukemia
-
2024-513547-82-00
5
2025-03-11
Transthyretin Amyloidosis
-
2024-511596-15-00
4
2024-12-26
Liver Diseases, Alcoholic
-
2023-509717-36-00
5
2024-12-16
AF patients who have undergone successful PCI
-
2024-519067-17-00
4
2024-12-02
Locally Advanced Pancreatic Cancer
-
2024-517863-22-00
5
2024-12-01
Study population consists in patients with a diagnosis of mCRC who hav
-
2024-512895-36-00
5
2024-11-25
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
-
2024-513009-30-00
4
2024-11-21
Moderate to Severe Crohn’s Disease
-
2023-504733-53-00
4
2024-09-26
Cushing's Disease
-
2024-510954-28-01
4
2024-09-23
grade 1, 2 and 3 meningioma
-
2023-506503-26-00
5
2024-07-31
Polyneuropathy, Inflammatory Demyelinating, Chronic
-
2023-505141-48-00
5
2024-03-07
Fibrosis
-
2022-502775-29-01
5
2023-12-14
Early stage Follicular Lymphoma
-
2024-518656-23-00
4
2023-09-01
locally advanced cholangiocarcinoma
-
2023-510431-11-00
4
2023-07-21
Chronic Lymphocytic Leukemia
-
2023-509868-20-00
5
2023-06-24
Acute coronary syndrome
-
2024-512878-98-00
9
2023-05-16
Brain Metastasis from Estrogen Receptor Positive, HER-2 Negative
Breas
-
2024-511631-10-00
9
2023-02-27
Hodgkin’s lymphoma
-
2024-515981-14-00
5
2022-12-14
Gastric adenocarcinoma with peritoneal metastases
-
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)